This comics book was developped by the Labonfoil projet, a research project funded by the European Commission. I am not the author, just uploaded so that people can view this magnificent piece of science dissemination.
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Comic labonfoil
1.
2. Contract no. 224306
LABONFOIL
Laboratory Skin Patches and SmartCards
based on foils and compatible with a
Smartbiophone.
INSTRUMENT: Large-scale integrating project (IP)
D2.3 Scenarios of Labcard and Skin Patch
Due Date of Deliverable: 1-7-2008
Completion Date of Deliverable: 28-9-2008
Start date of project: 1-5-2008 Duration: 31-4-2012
Responsible partner
for deliverable: IKERLAN Revision: v3.1
Project co-funded by the European Commission within
the 7th Framework Programme
Dissemination Level
PU Public ✘
PP Restricted to other programme participants (including the Commission Services)
RE Restricted to a group specified by the consortium (including Commission Services)
CO Confidential, only for members of the consortium (including Commission Services)
19. LABONFOIL
Vision Objectives
Portable diagnostic tools are urgently required to ensure rapid, The objective of the LabOnFoil project is to develop ultra-low-cost
affordable and simple analysis in many scenarios that will laboratories on chips (LOC) without compromising time
benefit our society (e.g. in; hospitals, airports, doctor’s practice, response, sensitivity or simplicity of use. The user will obtain
roadside police controls, natural environment). the test results using a very popular interface (a smartphone)
However, conventional analytical methods often require a large and a set of Labcards and skin patches, where the sample prepa-
volume of sample and complicated time-consuming protocols. ration and detection take place. The project will validate the
Current portable devices are based on less sensitive immunoch- devices in four applications:
romatographic strips or electrochemical detection systems, whe-
• Labcard for marine algae analyisis, climate change, CO2
reas desktop systems (though sensitive and semi-automatic) are sequestration, and toxic blooms.
bulky and heavy.
• Labcard for Salmonella spp. and Campylobacter spp. detection
in slaughter houses and farms.
• Labcard for Colorectal Cancer monitoring using blood.
• Skin patch for cocaine consumption testing of professional
drivers.
Strategy
Due to the biomicrofabrication results achieved within the
consortium and remarkable synergy with organic
optoelectronics, lamination and biological reactions,
the consortium can now seize the opportunity to
develop a fully integrated device with ultra-low cost.
The combination of these technologies will produce a
successful portable diagnostic device able to analyse all major
biomolecule classes (proteins, RNA and DNA) in a wide range of
applications. The future mass production of these novel diagnostic components
will be guaranteed by the development of manufacturing
The new testing devices will consist of a lab-on-a-chip (LOC)
equipment. This will provide, at last, a standardised solution to
embedded in a smartcard or a skin patch. The Labcard and Skin
manufacture truly ultra-low-cost Lab-on-a-chip microsystems. The
Patch components will be manufactured using a reel-to-reel
dramatic cost reduction will be based on the use of large films
system radically decreasing the price to 1% of existing systems
instead of wafer substrates. The smart mobile phone will offer
(wafer based).
a vast range of straightforward communication and interface
capabilities. This strategy will turn a smartphone into a portable
diagnostic device. The Labcards and the skin patches will
demonstrate the wide range of applications and the potential of
the technology.
20. Project Partners
www.labonfoil.eu
● IKERLAN-IK4, S.Coop. (Project Coordinator)
–Spain–
● GAIKER-IK4 Technological Centre
–Spain–
● University Of Southampton
–United Kingdom–
● Natural Environment
Research Council
–United Kingdom–
● Dep. Micro and Nanotechnology
(Danmarks Tekniske Universitet)
–Denmark–
● National Veterinary Institute
(Danmarks Tekniske
Universitet)
–Denmark–
● Fundación Vasca
De Innovación
E Investigación Sanitarias
–Spain–
● Politechnika Wroclawska
–Poland–
● Fraunhofer Gesellschaft Zur
Foerderung Der Angewandten
Forschung E.V.
–Germany–
● Biosensia Limited
–Ireland–
● TATAA Biocenter AB
–Sweden–
● EVGroup E. Thallner Gmbh
–Austria–
● Biotools Biotechnological &
Medical Laboratories S.A.
–Spain–
● Micro Resist Technology
–Germany–
● Gema Medical S.L.
–Spain–
Deliverable objective
The purpose of the diffusion of these four stories is to obtain
a feedback from interested people who read it. Feel free to contact
us or send us your opinion about the envisioned device and
its applications. It would be highly appreciated.
Contact
Jesús M. Ruano-López
IKERLAN-IK4, S.Coop.
J.Mª Arizmendarrieta, N. 2
20500 Arrasate-Mondragón
SPAIN
e-mail: jmruano@ikerlan.es
www.ikerlan.es
Web site: www.labonfoil.eu
Timeline: Start: 01-05-08
End: 30-04-12
Budget: Overall Cost: 7.097.808 €
EC Funding: 5.300.000 €
Supported by FP7
Contract number: 224306
